Sunitinib feasible after brain metastases surgeryPilot investigation suggests drug may offer alternative to radiation therapy Selumetinib shows promise in ovarian cancerOral MEK inhibitor produces ‘striking’ results in early clinical trial Metformin slows prostate cancer growth Small Canadian study measures markers of cell proliferation Hypoxia predicts prostate cancer recurrence Low tumour oxygenation linked with biochemical relapse within 48 months of treatment Trials fine-tune treatment of low-risk thyroid cancer Less radioiodine as effective as higher dose, studies show Beware circulating cells New study backs flexible sigmoidoscopy as screening tool Major U.S. trial shows reduction in colorectal cancer mortality Scan kids with caution Male pattern baldness linked to prostate cancer But finger-length ratio not a risk factor, Canadian study shows Statins may slow prostate growth Finding emerges from secondary analysis of dutasteride trial First Previous 50 51 52 53 54 Next Last
